The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

PERSPECTIVES IN TAVI IN 2014

Patient selection for TAVI in 2014: is it justified to treat low- or intermediate-risk patients? The cardiologist’s view

EuroIntervention 2014;10:U16-U21. DOI: 10.4244/EIJV10SUA3

Department of Cardiology, Hospital Charles Nicolle, University Hospital of Rouen, INSERM UMR 1096, Rouen, France

Twelve years after the first transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS), European and American guidelines, as well as the FDA, indicated that TAVI is the treatment of choice in “inoperable”

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Is it time to simplify the TAVI procedure? “Make it simple but not too simple”